William A. Gray, MD

Country USA
Specialty Interventional Cardiologist
  1. Evidence of DCB Treatment for Infrapopliteal Disease
  2. Leave Nothing and Suppress Restenosis: Drug-Coated Balloon
  3. Drug Eluting Stents and Bioresorable Scaffolds - What\'s the Latest News?
  4. New Design in Stent: Micromesh Technology Compared with Closed or Opened Cell Design
  5. Optimizing Outcomes with Tibial Atherectomy - What Experience and Data Have Taught Us
  6. Clinical Results and Ongoing Studies of New Drug Eluting Stent for SFA
  7. Invited Case Presentation & Focus Review: Between a Rock and No Place
  8. INSTEAD XL: Routine vs. Selective TEVAR
  9. How Shall We Change Our Practice on the Results of CREST/ICSS/ACT1?
  10. When Outcomes Matter, Design Matter
  11. Proximal Protection vs. Distal Protection in CAS
  12. ACTIVE Study: Co-Cr Balloon Expandable Stent : What Advantages over Standard Self-expandable Stent ?
  13. Drug-coated Balloon Technologies II: Clinical Outcomes and Recommended Applications
  14. Practical Aspects in FFR; When, Why and How to Use?
  15. From Puncture to Stent: Step by Step Technical Point Lessons from EVAR
  16. Evolving and Challenging Endovascular Techniques for SFA CTO
  17. Wrap Up Endovascular Outcomes of BTK Lesions and Future Directions
  18. Why CAS?
  19. Insights from EVEREST II: Clinical Utility of Transcatheter Edge-to-Edge Mitral Valve Repair
  20. Endovascular Abdominal Repair: Current Treatment and Future We Can Expect
  21. Endovascular Strategy for Aortoiliac Occlusive Disease: Patients Selection and Best Approach
  22. Achieving Optimal Clinical Results After Carotid Stenting: The PROTECT Study and Beyond...
  23. A Data-Driven Therapeutic Algorithm for Choosing Among Currently Available Tools for SFA Intervention
  24. When Is Revascularization Considered in Renal Artery Stenosis?
  25. Endovascular Repair of TAA & AAA
  26. Carotid Stenting
  27. Lower Extremity Revascularization: a Data-Driven Approach to SFA Disease